Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Illumina, Inc. - Common Stock (NQ:ILMN)

100.80 +0.46 (+0.46%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
32 33 Next >
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
SOURCE: Illumina 
Via 3BL Media
Illumina Launches Multiple-Gene Diagnostic Test For Cancer Patients
Illumina Inc (NASDAQ: ILMN) has launched TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the... 
Via Benzinga
Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India
SOURCE: Illumina 
Via 3BL Media
Illumina Named One of Fast Company's Most Innovative Companies for 2022
SOURCE: Illumina 
Via 3BL Media
Celebrating Women's History Month: Illumina Spotlights Scientist Geraldine Pittman Woods
SOURCE: Illumina 
Via 3BL Media
Illumina's Q4 Profit Falls Despite Topline Growth Of 26%
Illumina Inc (NASDAQ: ILMN) reported  
Via Benzinga
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Illumina's Technology Supports Biodiversity and Conservation Initiatives
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates Rare Disease Day
SOURCE: Illumina 
Via 3BL Media
CNBC's Final Trades: iShares MSCI UK, Illumina, US Silica And This Company That Has An Attractive Buyout Deal
On CNBC’s “Halftime Report... 
Via Benzinga
“The World Expands”: Celebrating Rare Disease Day in Japan
SOURCE: Illumina 
Via 3BL Media
Bionano Stock Looks to Have a Monster Comeback in Its Future
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly. 
Via InvestorPlace
African Coronavirus Surveillance Network Provides Early Warning for World
SOURCE: Illumina 
Via 3BL Media
Give peace a chance
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
Via Talk Markets
From Patents to Patients: Meet the Women Making a Difference at Illumina
SOURCE: Illumina 
Via 3BL Media
Topics Intellectual Property
Illumina to Support Neuro Genomics Project at McGill University
SOURCE: Illumina 
Via 3BL Media
Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More
This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to... 
Via Benzinga
Dominion Energy, Under Armour, And Expedia Among Another Slew Of Earnings Reports
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index... 
Via Benzinga
Expert Ratings For Illumina
Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
10 Biggest Price Target Changes For Friday
SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading. 
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Following Thursday's Plunge
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
5 Stocks To Watch For February 11, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Illumina: Q4 Earnings Insights
Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings... 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Illuminating Rare Disease: Get to Know SLC6A1 Connect
SOURCE: Illumina 
Via 3BL Media
Illumina Partners With Centers Across France to Advance a Precision Medicine Approach for Patients With Late-Stage Cancer
SOURCE: Illumina 
Via 3BL Media
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
How Far Can the Stock Market Fall?
The stock market as measured by the S&P 500 has been correcting since the start of the new year. Most of the damage has come from the significantly overvalued constituents. 
Via Talk Markets
Illumina Collaborates With National Cancer Center Japan to Address a Leading Cause of Death in Asia
SOURCE: Illumina 
Via 3BL Media
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.